A planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says it cannot proceed.
GoodRx reports five major changes to Medicare in 2026, including a $2,100 Part D out-of-pocket limit, prior authorization for ...
A new study examines the potential impact of the Medicare Prescription Payment Plan (M3P)—an opt-in policy implemented in ...
Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor used in adults with type 2 diabetes, chronic kidney disease ...
Should you get the same Medicare coverage as your spouse? As in most things in life, the answer is it depends.
GLP-1 meds are are highly effective at treating diabetes, obesity and other conditions. But when people stop using them, the ...
Senators Crapo and Wyden introduced PBM Transparency Act to lower drug prices. Bill would delink PBM rebates, boost reporting, and let plan sponsors audit PBMs. Transparency and NADAC participation ...
On December 19, 2025, the Centers for Medicare & Medicaid Services (“CMS”) proposed two mandatory Center for Medicare and Medicaid Innovation (“CMMI”) drug payment models to test whether alternative ...
Drugmakers are raising list prices on at least 350 medications in 2026. Medicare Part D caps out-of-pocket drug spending at $2,100 this year. So do the hikes still matter for seniors? Yes, but the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback